KRAS G12S Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies (NCT06720987) | Kumquat Biosciences Inc. | 2025-02-04 |
Track KRAS G12S Mutation automatically
Every clearance here is in the API, with alerts when new ones post.